Pancreatic Cancer Research

ResearcherUniversity of California San DiegoActive in the last 2 years

Laura Antonucci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3659-7334; OpenAlex author ID A5101404975. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. Co-author DOI 10.1073/pnas.2511733123↗
  2. Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer. Co-author DOI 10.1038/s43018-025-01003-3↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dafna Bar‐Sagi · 2 shared papers, 2025–2026 · strength 0.38
  2. Andrew M. Lowy · 2 shared papers, 2025–2026 · strength 0.38
  3. David W. Dawson · 2 shared papers, 2025–2026 · strength 0.38
  4. Michael Karin · 2 shared papers, 2025–2026 · strength 0.38
  5. Beicheng Sun · 1 shared paper, 2026 · strength 0.22
  6. Jonathan Weitz · 1 shared paper, 2026 · strength 0.22
  7. Hervé Tiriac · 1 shared paper, 2026 · strength 0.22
  8. Vidhi M. Shah · 1 shared paper, 2025 · strength 0.16
  9. Isidoro Cobo · 1 shared paper, 2025 · strength 0.16
  10. Terry K. Morgan · 1 shared paper, 2025 · strength 0.16
  11. Motoyuki Tsuda · 1 shared paper, 2025 · strength 0.16
  12. Rosalie C. Sears · 1 shared paper, 2025 · strength 0.16
  13. Guido Eibl · 1 shared paper, 2025 · strength 0.16
  14. Jelena Todoric · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.